PLUR:NASDAQ
Pluri Inc
$0.94
arrow_upward
+1.08%(+0.0100) 1D
Oct 15, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLUR...
Open
$0.93
High
$0.96
Low
$0.93
Mkt. cap
11.60M
Avg. vol.
17.20K
Volume
1.96K
52-wk high
$4.86
52-wk low
$0.85
EPS
-$2.44
Beta
0.69
Shares outstanding
12.61M
No. of employees
103
Open
$0.93
High
$0.96
Low
$0.93
Mkt. cap
11.60M
Avg. vol.
17.20K
Volume
1.96K
52-wk high
$4.86
52-wk low
$0.85
EPS
-$2.44
Beta
0.69
Shares outstanding
12.61M
No. of employees
103
News stories
From web sources and news partners
Business Wire
·
25 minutes ago
SITE Centers Announces Plan to De-list from NYSE
MarketBeat
·
5 minutes ago
High Tide Inc. (NASDAQ:HITI) Sees Significant Drop in Short Interest
Profile
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas. Wikipedia
About Pluri Inc
CEOYaky Yanay
Employees103
FoundedMay 11, 2001
HeadquartersHaifa, Haifa District, Israel
SectorBiotechnology
Websitepluri-biotech.com